Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,820 | -8,390 | -2,860 | -12,320 | -9,200 |
| Depreciation Amortization | 510 | 340 | 170 | 680 | 510 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -47 | N/A |
| Other Working Capital | 170 | -260 | -290 | 410 | 400 |
| Other Operating Activity | 5,390 | 1,760 | 380 | 2,687 | 1,880 |
| Operating Cash Flow | $-9,750 | $-6,550 | $-2,600 | $-8,590 | $-6,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -6 | 0 |
| Investing Cash Flow | $0 | $0 | $0 | $-6 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 6,519 | N/A |
| Other Financing Activity | 16,560 | 15,820 | 10,800 | 2,521 | 7,400 |
| Financing Cash Flow | $16,560 | $15,820 | $10,800 | $9,040 | $7,400 |
| Beginning Cash Position | 3,230 | 3,230 | 3,230 | 2,790 | 2,790 |
| End Cash Position | 10,040 | 12,500 | 11,440 | 3,230 | 3,780 |
| Net Cash Flow | $6,800 | $9,270 | $8,200 | $440 | $980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,750 | -6,550 | -2,600 | -8,590 | -6,410 |
| Capital Expenditure | N/A | N/A | N/A | -6 | N/A |
| Free Cash Flow | -9,750 | -6,550 | -2,600 | -8,596 | -6,410 |